
Analyst Insights
Recent developments with Enliven Therapeutics Inc (ELVN) have led to the company’s beta value being reach 0.79 cents.
On Tuesday, Enliven Therapeutics Inc (NASDAQ: ELVN) opened higher 14.21% from the last session, before settling in for the closing price of $19.14. Price fluctuations